B2B formulation evaluation

Natural-origin vesicle raw materials for cosmetic R&D teams.

Ecyto Biotech develops and manufactures extracellular vesicle / phyto-vesicle raw materials for skincare formulation testing. Our current evaluation candidates cover ginseng, Ganoderma lucidum, Polygonum cuspidatum, Gastrodia elata, and deer velvet antler. We support personal care ingredient distributors, OEM/ODM laboratories, and brand R&D teams with sample guidance and technical documents.

Positioning: These materials are intended for B2B cosmetic formulation evaluation. They are not human-source, stem-cell therapy, medical, or therapeutic products.

Candidate materials

Focused candidates for skincare concepts

Panax ginseng-derived vesicles

Anti-aging, firmness, antioxidant, and skin vitality formulation concepts.

  • Source focus: Changbai Mountain ginseng root.
  • Application fit: serum, ampoule, cream, and mask evaluation.

Ganoderma lucidum-derived vesicles

Fungal-origin soothing, barrier-support, and early-aging formulation concepts.

  • Source focus: Ganoderma lucidum mycelium and fruiting body.
  • Application fit: sensitive-skin, calming, and barrier-care lines.

Polygonum cuspidatum-derived vesicles

Antioxidant care and oil/acne-prone skin formulation concepts.

  • Source focus: Japanese knotweed root rich in resveratrol-related actives.
  • Application fit: antioxidant, brightening, and acne-prone concepts.

Gastrodia elata-derived vesicles

Hydration, calming, antioxidant, and sensitive-skin formulation concepts.

  • Source focus: mature Gastrodia elata tubers.
  • Application fit: daily repair, dullness, and mild post-aesthetic concepts.

Deer velvet antler-derived vesicles

Animal-origin candidate for customers who can support local compliance review.

  • Application fit: intensive repair and anti-aging concept evaluation.
  • Availability: discussed case by case, not the default Southeast Asia launch focus.

Partner fit

Built for early technical evaluation

01

Lyophilized sample format for early formulation evaluation and logistics simplicity.

02

Reconstitution guidance, cool-down phase addition, dosage screening, and compatibility review.

03

Batch-specific technical documents shared as evaluation becomes relevant.

04

Support for concept positioning, sample protocols, and distributor/OEM technical discussions.

Regulatory positioning

Clear boundaries for early-stage B2B review

INCI naming route INCI naming applications for ginseng, Ganoderma lucidum, and Polygonum cuspidatum vesicle candidates are being prepared. INCI naming is an ingredient-name assignment process, not a product approval.
Cosmetic-only communication Public materials avoid human-source, stem-cell therapy, medical treatment, wound-healing, or drug-grade claims.
Technical review package TDS, SDS, COA, NTA/TEM data, safety brief, and sample protocols can be shared during NDA or qualified technical review.

Evaluation package

Documents for R&D and sourcing review

Technical introduction Preliminary one-page B2B formulation overview Sample testing plan Suggested sample handling and formulation evaluation flow
Further documents TDS, SDS, COA, NTA/TEM data, and safety brief can be shared during technical review.

Contact

Discuss a sample evaluation or distributor fit.

For OEM/ODM laboratories, personal care ingredient distributors, and skincare R&D teams, please contact our overseas business team.

Runji Yang General Manager, Overseas Business runji.yang@ecytobiotech.com ecytobiotech.com LinkedIn company page

Floors 1-4, Building 3, South of East-West No.4 Road in Chang'an Communication Industrial Park, 140 meters east of the intersection of Runfeng Road and Qianyuan Road, High-tech Zone, Xi'an City, Shaanxi Province, China.